Recovery of lymphocyte and dendritic cell subsets after autologous CD34+ cell transplantation

被引:25
作者
Galy, A [1 ]
Rudraraju, S [1 ]
Baynes, R [1 ]
Klein, J [1 ]
机构
[1] Wayne State Univ, Barbara Ann Karmanos Canc Inst, Stem Cell Transplantat Program, Detroit, MI 48201 USA
关键词
dendritic cells; naive T cells; CD34(+) cell transplant; flow cytometry;
D O I
10.1038/sj.bmt.1702454
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Following high-dose chemotherapy (HDC) and peripheral blood progenitor cell transplantation (PBPCT), there are profound changes in leukocyte homeostasis and the immune system is compromised. Transplantation of purified CD34(+) cells may further compromise immune recovery because the grafts are depleted of mature immune cells. However, a detailed monitoring of immune cell reconstitution has not been done. We monitored blood levels of antigen-presenting cells (APC) and of lymphocytes by multi-color flow cytometry at different times post CD34(+) PBPCT. We found a rapid normalization of circulating levels of the antigen-presenting CD11c(+) dendritic cells (defined as lineage(-) HLA-DR+ CD11c(+) cells). There was a slight over-representation of lin(-) DR+ CD11c(-) cells at day 42 post transplantation suggesting that the composition of the APC population might be affected. Normal levels of total T, B and NK lymphocytes were rapidly achieved but the composition of the T cell population was abnormal. Patients had elevated levels of CD8(+) T cells at early times and a persistent reduction in levels of naive CD8(+) T cells (CD8(+) CD4- CD45RA(+) CD27(+)) and of naive CD4(+) T cells (CD4(+) CD3(+) CD8(-) CD45RA(+)). Thus, we found a rapid recovery of DC after CD34(+) PBPCT but the specific numerical defects in naive T cells are likely to be a major cause of immune dysfunction in the patients.
引用
收藏
页码:1249 / 1255
页数:7
相关论文
共 29 条
[1]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[2]  
CAYEUX S, 1989, BLOOD, V74, P2278
[3]   Autografting of highly purified peripheral blood progenitor cells following myeloablative therapy in patients with lymphoma: a prospective study of the long-term effects on tumor eradication, reconstitution of hematopoiesis and immune recovery [J].
Dreger, P ;
Viehmann, K ;
von Neuhoff, N ;
Glaubitz, T ;
Petzoldt, O ;
Glass, B ;
Uharek, L ;
Rautenberg, P ;
Suttorp, M ;
Mills, B ;
Mitsky, P ;
Schmitz, N .
BONE MARROW TRANSPLANTATION, 1999, 24 (02) :153-161
[4]   Monitoring human blood dendritic cell numbers in normal individuals and in stem cell transplantation [J].
Fearnley, DB ;
Whyte, LF ;
Carnoutsos, SA ;
Cook, AH ;
Hart, DNJ .
BLOOD, 1999, 93 (02) :728-736
[5]   Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation [J].
Guillaume, T ;
Rubinstein, DB ;
Symann, M .
BLOOD, 1998, 92 (05) :1471-1490
[6]   Phenotypic and functional separation of memory and effector human CD8(+) T cells [J].
Hamann, D ;
Baars, P ;
Rep, MHG ;
Hooibrink, B ;
KerkhofGarde, SR ;
Klein, MR ;
vanLier, RAW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (09) :1407-1418
[7]   Dendritic cells: Unique leukocyte populations which control the primary immune response [J].
Hart, DNJ .
BLOOD, 1997, 90 (09) :3245-3287
[8]   Cyclophosphamide and paclitaxel as initial or salvage regimen for the mobilization of peripheral blood progenitor cells [J].
Klein, JL ;
Rey, PM ;
Dansey, R ;
Karanes, C ;
Abella, E ;
Cassells, L ;
Hamm, C ;
Flowers, M ;
Couwlier, C ;
Peters, WP ;
Baynes, RD .
BONE MARROW TRANSPLANTATION, 1999, 24 (09) :959-963
[9]  
Kohrgruber N, 1999, J IMMUNOL, V163, P3250
[10]   AGE, THYMOPOIESIS, AND CD4+ T-LYMPHOCYTE REGENERATION AFTER INTENSIVE CHEMOTHERAPY [J].
MACKALL, CL ;
FLEISHER, TA ;
BROWN, MR ;
ANDRICH, MP ;
CHEN, CC ;
FEUERSTEIN, IM ;
HOROWITZ, ME ;
MAGRATH, IT ;
SHAD, AT ;
STEINBERG, SM ;
WEXLER, LH ;
GRESS, RE .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (03) :143-149